PRIMARY STUDY

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases

Key Findings:  CBD, which interacts with the eCB system, but has also cannabinoid receptor-independent mechanism, might be a good candidate as a prototype for anti-oxidant drug development for the major neurodegenerative disorders, such as PD and AD.

Type of Study:  Meta-analysis

Study Result:  Positive


Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype III

Form of Administration:  Not Applicable

Sub-Ratio: 0:1 (THC:CBD)


Study Location(s):  Italy, Poland

Year of Pub:  2020


Link to study